Paracoccidioidomycosis: Current Perspectives from Brazil
- Open Microbiol J. 2017 Oct 31;11:224-282. doi: 10.2174/1874285801711010224.
- 1. Department of Tropical Diseases, Faculdade de Medicina de Botucatu - São Paulo State University - UNESP, São Paulo, Brazil.
- 2. Department of Dermatology, Faculdade de Medicina de Botucatu - São Paulo State University - UNESP, São Paulo, Brazil.
- 3. Department of Pathology, Faculdade de Medicina de Botucatu - São Paulo State University - UNESP, São Paulo, Brazil.
- 4. Laboratory of Experimental Immunology, Department of Biological Science, Faculty of Science, São Paulo State University - UNESP, São Paulo, Brazil.
- 5. Department of Infectious and Parasitic Diseases, Faculdade de Medicina - Federal University of Mato Grosso do Sul - UFMS, Brazil.
- 6. Instituto Lauro de Souza Lima, São Paulo State, Bauru, Brazil.
- 7. Unit of Experimental Research, Faculdade de Medicina de Botucatu - São Paulo State University - UNESP, São Paulo, Brazil.
- 8. Department of Microbiology and Immunology - Instituto de Biociências de Botucatu - São Paulo State University - UNESP, São Paulo, Brazil.
- 9. Laboratory of Investigation and Mycology, Federal University of Mato Grosso, Faculty of Medicine Cuiabá, Mato Grosso, Brazil.
Background: This review article summarizes and updates the knowledge on paracoccidioidomycosis. P lutzii and the cryptic species of P. brasiliensis and their geographical distribution in Latin America, explaining the difficulties observed in the serological diagnosis.
Objectives: Emphasis has been placed on some genetic factors as predisposing condition for paracoccidioidomycosis. Veterinary aspects were focused, showing the wide distribution of Infection among Animals. The cell-mediated immunity was better characterized, incorporating the recent findings.
Methods: Serological methods for diagnosis were also compared for their parameters of accuracy, including the analysis of relapse.
Results: Clinical forms have been better classified in order to include the pictures less frequently observesiod.
Conclusion: Itraconazole and the trimethoprim-sulfamethoxazole combination was compared regarding efficacy, effectiveness and safety, demonstrating that azole should be the first choice in the treatment of paracoccidioidomycosis.